A phase II trial of pegylated interferon (alpha)-2b therapy for polycythemia vera and essential thrombocythemia: feasibility, clinical and biologic effects, and impact on quality of life

Authors :: Samuelsson, Jan
Hasselbalch, Hans
Bruserud, Oystein
Temerinac, Snezana
Brandberg, Yvonne
Merup, Mats
Linder, Olle
Bjorkholm, Magnus
Pahl, Heike L.
Birgegard, Gunnar
Source :: Cancer. June 1, 2006, Vol. 106 Issue 11, p2397, 9 p.
Publication Year :: 2006

Subjects :: Polycythemia vera -- Drug therapy
Thrombocythemia -- Drug therapy
Thrombocytosis -- Drug therapy
Interferon alpha -- Dosage and administration
Interferon alpha -- Research
Quality of life -- Research
Drug therapy -- Patient outcomes
Drug therapy -- Research
Health

Tools